Biotech

AgTech Innovator Enko Chem Announces CEO Transition

March 3, 2025

Suffolk Celebrates Topping off for a Game-Changing New Takeda Facility in Kendall Square Where Science, Art and Community Will Converge

January 30, 2025

TreeFrog Therapeutics Leases 13,488 Square Feet at Cambridgeport Labs

January 6, 2025

THIS WEEK'S STORIES

Slowing Construction and Rising Capital Flows Set Stage for Life Sciences Market Rebound

March 5, 2025

Endologix Appoints Andrew Davis as Chief Commercial Officer

March 3, 2025

Emids Names Veteran Healthcare and Digital Transformation Executive Abhishek Shankar as CEO to Support its Next Phase of Growth

March 5, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility

Colossal Creates the Colossal Woolly Mouse, Showcasing Breakthroughs in Multiplex Genome Editing and Trait Engineering on the Path to a Mammoth

Immunis’ Treats its First Patients for Sarcopenic Obesity

Epredia Receives U.S. FDA 510(K) Clearance for the E1000 Dx™ Digital Pathology Solution Designed to Improve Laboratory Workflow in Cancer Diagnostics

HighByte Launches API Builder for Industrial Data

Most Read

Almirall Announces CFO Transition Plan and Appoints Jon U. Garay Alonso as CFO to Succeed Mike McClellan in August 2025

Evidation Appoints Leslie Oley Wilberforce as CEO

Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care

Freed Secures $30M Series A Led by Sequoia Capital to Free Clinicians from Administrative Burdens with AI Assistant

EDITOR PICKS